(a)
|
The
reasons described in reasonable detail in Part III of this form could
not
be eliminated without unreasonable effort or
expense;
|
x
|
(b)
|
The
subject annual report or semi-annual report/portion thereof will
be filed
on or before the fifteenth calendar day following the prescribed
due date;
or the subject quarterly report/portion thereof will be filed on
or before
the fifth calendar day following the prescribed due date;
and
|
(c)
|
The
accountant’s statement or other exhibit required by Rule 12b-25(c) has
been attached if applicable.
|
(2)
|
Have
all other periodic reports required (under Section 13 or 15(d) of
the
Securities and Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940) during the preceding 12 months (or for such
shorter
period that the registrant was required to file such reports) been
filed?
If answer no, identify report(s).
|
(3)
|
Is
it anticipated that any significant change in results of operations
from
the corresponding period for the last fiscal year will be reflected
by the
earnings statement to be included in the subject report or portion
thereof?
|
If
so, attach an explanation of the anticipated change, both narratively
and
quantitatively, and; if appropriate, state the reasons why a reasonable
estimate of the results can not be
made.
|
BIOMETRX, INC. | ||
|
|
|
Date: August 14, 2007 | By: | J. Richard Iler |
J. Richard Iler, Chief Financial Officer |